Emtricitabine Recruiting Phase 3 Trials for Substance Use Disorders (SUD) / Stimulant Use / Human Immunodeficiency Virus (HIV) Infections Prevention

IndicationsStatusPurposePhase
RecruitingPrevention3
clinicaltrials.gov IdentifierTitleDrugs
NCT03965923Randomized, Open Label Safety Trial of Dapivirine Vaginal Ring and Oral TRUVADA® Use in Pregnancy
NCT03512418Development of Ingestible Biosensors to Enhance PrEP Adherence in Substance Users (PrEPSteps)
NCT03164564Evaluating the Safety and Efficacy of Long-Acting Injectable Cabotegravir Compared to Daily Oral TDF/FTC for Pre-Exposure Prophylaxis in HIV-Uninfected Women